Frailty Medicines Optimisation Specialist | Flexible NHS Role

Kent Community Health NHS Foundation Trust; Ashford; On-site; GBP 42,000 - 56,000; Full time

Job summary

Kent Community Health NHS Foundation Trust is recruiting a Specialist Clinical Pharmacist Frailty to optimise medicines for patients in home and community hospital settings. You will work within the Integrated Pharmacy Team, advising on frailty-related pharmacotherapy and collaborating with multidisciplinary colleagues to improve patient outcomes.

The role involves medicines reconciliation, clinical development, and potential pathways to independent prescribing, with a focus on safe transfers of

Responsibilities

• Optimising medicines through medication reviews for patients in their own home or community hospital setting
• Ensuring safe transfer of care into community hospitals including medicines reconciliation
• Participation in KCHFT and primary care network (PCN) multidisciplinary team patient reviews
• Assessment of concordance and implementation of appropriate interventions
• Providing responses to medication queries
• Provision of legal and ethical advice as appropriate for the service provision
• Undertaking clinical development and contributing to the development of others
• Supporting training to staff within the pharmacy service
• Where required undertake training to become an independent prescriber
• Supporting and facilitating Quality Improvement (QI)
• Liaising with key stakeholders in order to explore identified risk areas

Skills

Medicines optimisation

Clinical pharmacist

Interdisciplinary collaboration

Training staff

Prescribing (independent prescriber)

Job description

Kent Community Health NHS Foundation Trust is recruiting a Specialist Clinical Pharmacist Frailty to optimise medicines for patients in home and community hospital settings. You will work within the Integrated Pharmacy Team, advising on frailty-related pharmacotherapy and collaborating with multidisciplinary colleagues to improve patient outcomes.

The role involves medicines reconciliation, clinical development, and potential pathways to independent prescribing, with a focus on safe transfers of